| ALK+ Lymphoma: Clinico-Pathological Findings and Outcome B Falini, S Pileri, PL Zinzani, A Carbone, V Zagonel, C Wolf-Peeters, ... Blood, The Journal of the American Society of Hematology 93 (8), 2697-2706, 1999 | 795 | 1999 |
| Second-order moving average and scaling of stochastic time series E Alessio, A Carbone, G Castelli, V Frappietro The European Physical Journal B-Condensed Matter and Complex Systems 27 (2 …, 2002 | 505 | 2002 |
| Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled … V Galimberti, BF Cole, G Viale, P Veronesi, E Vicini, M Intra, G Mazzarol, ... The Lancet Oncology 19 (10), 1385-1393, 2018 | 445 | 2018 |
| A multicenter study of treatment of primary CNS lymphoma AJM Ferreri, M Reni, F Pasini, A Calderoni, U Tirelli, A Pivnik, GM Aondio, ... Neurology 58 (10), 1513-1520, 2002 | 438 | 2002 |
| HIV-associated lymphomas and gamma-herpesviruses A Carbone, E Cesarman, M Spina, A Gloghini, TF Schulz Blood, The Journal of the American Society of Hematology 113 (6), 1213-1224, 2009 | 434 | 2009 |
| EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues MP Martelli, G Sozzi, L Hernandez, V Pettirossi, A Navarro, D Conte, ... The American journal of pathology 174 (2), 661-670, 2009 | 411 | 2009 |
| EBV-associated lymphoproliferative disorders: classification and treatment A Carbone, A Gloghini, G Dotti The oncologist 13 (5), 577-585, 2008 | 376 | 2008 |
| ALK expression defines a distinct group of T/null lymphomas (“ALK lymphomas”) with a wide morphological spectrum B Falini, B Bigerna, M Fizzotti, K Pulford, SA Pileri, G Delsol, A Carbone, ... The American journal of pathology 153 (3), 875-886, 1998 | 366 | 1998 |
| Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma M Esteller, G Gaidano, SN Goodman, V Zagonel, D Capello, B Botto, ... Journal of the National Cancer Institute 94 (1), 26-32, 2002 | 359 | 2002 |
| The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape D Aldinucci, A Gloghini, A Pinto, R De Filippi, A Carbone The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010 | 341 | 2010 |
| Analysis of the resonant components in R Aaij, C Abellan Beteta, B Adeva, M Adinolfi, C Adrover, A Affolder, ... Physical Review D—Particles, Fields, Gravitation, and Cosmology 86 (5), 052006, 2012 | 339 | 2012 |
| Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study C Simonelli, M Spina, R Cinelli, R Talamini, R Tedeschi, A Gloghini, ... Journal of Clinical Oncology 21 (21), 3948-3954, 2003 | 321 | 2003 |
| Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts U Klein, A Gloghini, G Gaidano, A Chadburn, E Cesarman, ... Blood, The Journal of the American Society of Hematology 101 (10), 4115-4121, 2003 | 298 | 2003 |
| Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection S De Vita, C Sacco, D Sansonno, A Gloghini, F Dammacco, M Crovatto, ... Blood, The Journal of the American Society of Hematology 90 (2), 776-782, 1997 | 289 | 1997 |
| Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus–associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid … V De Re, S De Vita, A Marzotto, M Rupolo, A Gloghini, B Pivetta, ... Blood, The Journal of the American Society of Hematology 96 (10), 3578-3584, 2000 | 277 | 2000 |
| Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus–related lymphomas A Carbone, A Gloghini, LM Larocca, D Capello, F Pierconti, V Canzonieri, ... Blood, The Journal of the American Society of Hematology 97 (3), 744-751, 2001 | 275 | 2001 |
| MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival B Zheng, P Fiumara, YV Li, G Georgakis, V Snell, M Younes, JN Vauthey, ... Blood 102 (3), 1019-1027, 2003 | 271 | 2003 |
| Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. U Tirelli, D Errante, R Dolcetti, A Gloghini, D Serraino, E Vaccher, ... Journal of clinical oncology 13 (7), 1758-1767, 1995 | 266 | 1995 |
| Lymphomas expressing ALK fusion protein (s) other than NPM-ALK B Falini, K Pulford, A Pucciarini, A Carbone, C De Wolf-Peeters, J Cordell, ... Blood, The Journal of the American Society of Hematology 94 (10), 3509-3515, 1999 | 265 | 1999 |
| Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia D Capello, U Vitolo, L Pasqualucci, S Quattrone, G Migliaretti, L Fassone, ... Blood, The Journal of the American Society of Hematology 95 (2), 651-659, 2000 | 262 | 2000 |
